chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Week before Thanksgiving left leg went numb. Ignored..Thought was exercise/gym related. Early December, numbness interfered with pain perception left foot. Noticed pain when handwashing both hands 1/22/10 Numbness progressed to bilateral with severe tingling, some dysfunction in hands - Went to PCP - Placed on unknown med...return in two weeks 1/29/10 ER visit, right leg dragging... suspected MS Discharged to Neurologist. 2/1 ER Severe bilateral dysfunction - admitted to Hospital.  Blood tests normal MRI Diagnosis =  Transverse Myelititis. 2nd Consult Neuro concurred... Vaccine Related  Discharged to Rehab Facility. Some return of function to left leg and hands (Hands still not easy to manipulate)  Brace to right leg. Currently working on wheelchair transfers, stair climb with brace.. Discharged to Home with PT.
Pt recvd 3 doses of Engerix-B vax 17OCT90, 26NOV90, & 12APR91 & was found to be a non-responder;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age.  No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2011, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance the intended purpose of the long term prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2016, the patient was treated for the onset of a severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX vaccine  for long-term prevention of shingles, The patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses,and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Arm pain/ unable to lift arm, headache, chills, joint pain (lasting 3+ days)swollen gland.  Rash 04/14/2015.
Approximately 10 hours after vaccine, developed severe body aches, headache with fever 102 degrees oral. Persisted through 9/25/14; fever broke at 4:00 pm then returned that evening to 100.2 degrees. Seen by private doctor who indicated apparent reaction to influenza vaccine. Obtained lab work and chest x-ray (results not available to us as employer).
RIGHT OPHTHALMIC STROKE; LEFT SIDED WEAKNESS; CHILLS; This spontaneous report received from a physician concerned a 59 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, and seizures. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the patient experienced chills, tremor. On 10-APR-2021 15:00, the patient presented to hospital he was hunched over, gait was unsteady, and stated that over the past day left side gotten weaker, unable to decide the feeling, reports of numbness, decreased strength to left side, shuffling gait. On the same day, 10-Apr-2021, patient was hospitalized with symptoms of stroke, and was diagnosed with right ophthalmic stroke. The patient was in the hospital for 4 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 : 20210427690-covid-19 vaccine ad26.cov2.s -RIGHT OPHTHALMIC STROKE, LEFT SIDED WEAKNESS . This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE.
Moderna booster #2 was administered on 03/31/22 - the posts with all the pertinent vaccine information, had it listed to give 0.5 ml of the red top Moderna vaccine for the #2 booster.  It was supposed to only be 0.25 ml.  This error was caught on 04/05/2022.  Patient was notified and no adverse effects were noted post vaccine.
Site: Pain at Injection Site-Mild, Systemic: Tingling (specify: facial area, extremities)-Mild, Additional Details: Patient experienced tingling after her first dose, also. This time it started in her right leg, then moved to her left-side. It continued to move around her body.
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced confirmed immunological vaccine failure. Laboratory data (dates unspecified) included: SARS-CoV-2 antibody test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed immunological vaccine failure. This report was non-serious.
her husband said he got itchy immediately after receiving his first COVID-19 Vaccine; She clarified her husband's rash is on both sides of his left and right upper abdomen, between his ribs and hips, and on both his left and right shins; a week after her husband received his first COVID-19 Vaccine dose, he said he felt so bad; her husband said he felt run down a week after he received his first COVID-19 Vaccine dose; Injection site pain; This is a spontaneous report from a contactable consumer (patient's wife). A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3302, Expiration date: Not reported) via an intramuscular route of administration, administered in Arm Left on 12Jan2021 1ST DOSE, SINGLE DOSE for COVID-19 immunization. Medical history included ongoing psoriasis, Allergic to penicillin. The patient's concomitant medications were not reported. It was reported that her husband had the same experience after he received his first COVID-19 Vaccine dose on 12Jan2021, clarifying her husband said he got itchy immediately after receiving the COVID-19 Vaccine. She said her husband has had psoriasis for a long time. She said her husband has had psoriasis outbreaks before, but not in that area of his body. She said her husband usually has a psoriasis outbreak at his waist where his belt buckle is located, as well as, his elbows, and knees. She said her husband doesn't have any allergies, except for Penicillin. She said her husband didn't think anything of his itchiness and rash after he received his first dose of the COVID-19 Vaccine because he has a history of psoriasis. She said the rash he developed after his first COVID-19 Vaccine dose went away. She clarified her husband's rash is on both sides of his left and right upper abdomen, between his ribs and hips, and on both his left and right shins. She said a week after her husband received his first COVID-19 Vaccine dose, he said he felt so bad, and felt run down. She said he was told at that time what to expect after receiving the COVID-19 Vaccine, and after a couple days he was OK. She said her husband said his left arm was so painful with the first COVID-19 Vaccine dose, that he said couldn't put on his shirt. The outcome of the events was recovered on Jan2021.  Follow-up attempts are completed. No further information is expected.
About 9PM-10PM patient starting having body cramps, nausea, diarrhea, vomiting, chills (no fever), and headache x 3 days. Reports after 3 days symptoms started tapering off, but does continue to have dull headache and some nausea.
Shortly after receiving the vaccine on 10/6/2023, a round knot or bump formed at the injection site in my right arm.  It was a little over one inch in diameter, and by the next day I had a red rash about 2 inches in diameter.  The area was sore and itchy.  It has taken about four weeks for the rash to go away.  Although the knot is not as large as it was most of October, I still have the bump and it is still about an inch in diameter.
generalized tonic clonic sz x 40 mins required Ativan x 3 & Dilantin;
10 minutes after injection tongue started to tingle and swell. Remained at facility an additional 15 minutes. Blood pressure normal. Went home and took Benadryl. Within 48 hrs back to normal.
This spontaneous report as received from certified professional in healthcare quality (CPHQ) refers to an unspecified number of patients of unknown age (gender not reported) who may have been administered a dose (doses) of PNEUMOVAX23 (dose, route, lot number not reported) which went out of temperature range (unknown) for an unspecified amount of time. No adverse effects have been reported. Additional information has been requested.
Upset stomach; he feels like he wants to throw up; Sense of pressure in the head; Body aches; Feeling dizzy; Light nose bleeds/he would smell his own blood, sneezes, and blood would come out; Headache; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Light nose bleeds/he would smell his own blood, sneezes, and blood would come out), ABDOMINAL DISCOMFORT (Upset stomach; he feels like he wants to throw up), HEAD DISCOMFORT (Sense of pressure in the head), DIZZINESS (Feeling dizzy) and MYALGIA (Body aches) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2022, the patient experienced HEADACHE (Headache). On 13-Jan-2022, the patient experienced EPISTAXIS (Light nose bleeds/he would smell his own blood, sneezes, and blood would come out) and DIZZINESS (Feeling dizzy). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach; he feels like he wants to throw up), HEAD DISCOMFORT (Sense of pressure in the head) and MYALGIA (Body aches). At the time of the report, EPISTAXIS (Light nose bleeds/he would smell his own blood, sneezes, and blood would come out), ABDOMINAL DISCOMFORT (Upset stomach; he feels like he wants to throw up), HEAD DISCOMFORT (Sense of pressure in the head), DIZZINESS (Feeling dizzy), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. On 12-Jan-2021, the patient had a headache all day yesterday. This was an expected side effect, so the patient was not so concerned. But the patient woke up todayon 13-Jan-2022 and started having light nose bleeds and had been feeling dizzy. The patient would smell his own blood, sneezes, and blood would come out. The patient was also experiencing upset stomach; feels like wants to throw up, body aches, and a sense of pressure in the head. Treatment medications were not reported.   This case was linked to MOD-2022-451004 (Patient Link).
Started as a small bump and increased in size to a 2.5cm circular raised erythema area warm to touch.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On an unspecified date in August 2016 (reported as between 15-AUG-2016 and 26-AUG-2016), the patient might have been vaccinated with an improperly stored dose of GARDASIL 9 (lot # L043214, expiration date 30-AUG-2017; exact dose, site and route of administration were not reported. The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine was exposed to temperature of 28.6 Fahrenheit (F) degrees for 258.45 hours before administration to the patient. No previous temperature excursion was reported. No adverse effects were reported. Additional information has been requested.
I recently was diagnosed with kidney vasculitis; Other vaccine same date vaccine date 26Feb2021; This is a spontaneous report from a contactable consumer. A 70-year-old male consumer received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number en6200) via an unspecified route of administration on 26Feb2021 (at the age of 70-year-old) in arm left at 05:00PM at single dose for COVID-19 immunisation. The patient received also the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number en6204) via an unspecified route of administration on 26Feb2021 (at the age of 70-year-old) in arm left at single dose for COVID-19 immunisation. Relevant medical history included diabetes and high blood pressure. Concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient had not known allergies, nor COVID prior vaccination. He was not tested for COVID post vaccination. The patient had normal kidney function prior to the injection and was recently diagnosed with kidney vasculitis, on 21Aug2021. The event resulted in Doctor or other healthcare professional office/clinic visit. The patient was not recovered from vasculitis, outcome for overdose was unknown.
Pt was found dead of unknown cause the morning after immuns were given. Child was sleeping in bed with mom.  4/20/07 Received Autopsy Report which reveals COD as asphyxia, cannot exclude parental overlay.  Patient found face doen position after co-sleeping w/parents.  Final dx also included dilation of left renal pelvis.
Information has been received from a nurse practitioner concerning a 14 year old female who on 23-JUN-2008 was vaccinated with the first dose of GARDASIL (LOT# 660553/0070X). The nurse reported that the patient began to collapse off the table after receiving her first dose of GARDASIL. The nurse reported that she managed to catch the patient and move her from the table down to a chair in the room where the patient then experienced a petite mal seizure that lasted for about 5 minutes. The nurse also reported that within 3 to 5 seconds after the patient received the vaccination she passed out. The patient "came to" and was helped to a chair. The patient then had a petit mal seizure that lasted from 3 to 5 seconds. The nurse stated that the patient had a vasovagal reaction with a petit mal seizure. When the patient "woke up", it was reported that she was groggy. The nurse stated that the patient remained in the office for a while until she was stable enough to go home. The nurse spoke to the patient's mother via telephone conversation later that day, and the patient's mother reported that the patient was resting and was eating. The patient was reported to be "ok" with no long-term effects from the petit mal seizure. The nurse did not know if the patient was scheduled to receive the second dose of GARDASIL. Upon internal review, petite mal seizure was considered to be an other important medical event. Additional information has been requested.
The next day, "my" sinuses were stuffed up and "I" still had a headache; "My" arm was sore right away; "I" got a headache; Felt queasy several hours after getting the vaccine; "I" had a difficult time eating dinner and threwup later in the evening; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the right arm on an unknown date in Mar2021 at 13:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included levothyroxine/liothyronine (NP THYROID) for an unknown indication from an unknown date and unknown if ongoing. On 12Mar2021 at 17:00, the patient experienced sore arm right away, got a headache and felt queasy several hours after getting the vaccine. On the same day, the patient had a difficult time eating dinner and threw up later in the evening. On 13Mar2021, the next day, the patient experienced stuffed up sinuses and still had a headache. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events sore arm, headache, felt queasy, stuffed up sinuses, difficult time eating dinner and threw up later in the evening were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
No adverse reaction, pt received vaccine beyond use date of 9/19/22. Vaccine expiration is 11/30/22. Pt contacted by provider.  Pt reports no reaction to vaccine at this time. Per pt, "She will peruse another clinic that knows what they are doing"
thyroiditis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. .  A 63-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; NUCALA, since 2019 (Batch/Lot number: unknown) for asthma; budesonide, SYMBICORT, (Batch/Lot number: unknown). The patient's relevant medical history included: "Severe asthma" (unspecified if ongoing), notes: Severe asthma. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1), for COVID-19 immunization. The following information was reported: THYROIDITIS (non-serious) with onset 2021, outcome "unknown". The action taken for mepolizumab was unknown. The action taken for budesonide, formoterol fumarate was temporarily withdrawn.  Additional information: It was reported that she took Symbicort with Nucala and she did not take Symbicort for a few days because she ran out of it and so on 26Jul2022 to 29Jul2022 she was having some chest tightness. She attributed the chest tightness to maybe not taking Symbicort or due to receiving underdose of Nucala. As reported, the customer did not get the full dose of Nucala Al. She started Nucala AI in 2019 for diagnosis of severe asthma, but she stated in Apr2021 she after receiving the second dose of the COVID-19 (name unknown) she was diagnosed with thyroiditis and was started on medication for it. She attributed the thyroiditis to the COVID-19 vaccine. She stated in Apr2022 she received the booster dose of Pfizer vaccine on 18Apr2022 and 10 days later she started to experience dizziness/ lightheadedness and she was diagnosed with vestibular neuritis and she takes ibuprofen for it. The dizziness had gotten better but still there.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse via Poison and Drug Center (PDC) (MFR# US15-036295) referring to a patient of unknown gender, between the age of 6 years and 12 years old. There was no medical history, drug reaction or concomitant medication reported. The reporter stated the single-dose vial of PROQUAD (Merck) underwent temperature excursion as follows: on 26-MAY-2015, 5.3 degrees Celsius for 2 hours and 8 minutes. On 23-JUN-2015 the patient was vaccinated with the PROQUAD (Merck) lot # K014798, expiration date: 12-MAR-2016 (dose, strength, frequency, route and indication were not reported). No adverse event was reported. This is one of several reprots received from the same source: US15-036288, US15-036289, US15-035294, US15-036293, US15-036292, US15-036291, US15-036290. Additional information has been requested.
Approx 3-4 hrs post vax pt exp local inject site erythema & mildly pruritic erythematous rash on chest;
Within 7 minutes my throat was swollen to the point I couldn?t swallow, and could barely breathe, I was shaking, lightheaded,  and my heart beating rapidly.  The Walgreens pharmacist shot me with an epi pen.
Headache, pain on the right side, body aches, fever. Couldn't move on the right. Got progressively worse. Ultimately diagnosed with MS. Vaccine brought out a virus.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. On 19-JUN-2015, the patient was vaccinated with expired dose of GARDASIL (0.5 ml, intramuscular, lot# 0963AA, expiry date: 09-NOV-2013) (expired product administered). The vaccine was never undergone any temperature excursions (incorrect product storage). Concomitant medications were unspecified by reported. No adverse event was reported. The outcome of the events was unknown. No further information was provided. Additional information has been requested.
Two months post third dose of hepatitis B vax, the pt lost eye brows and eye lashes. Before vax, the pt was a happy, go-lucky child; now she is terrified and wants to isolate self.
Night following shot, I slept badly and felt cold all night.  When I wanted to get up to go to the bathroom around 5:30 AM, I could not get myself off and out of the bed.  It was like my legs wouldn't work. When I was finally up, I had no control of my bladder and urinated all the way into my bathroom. When I was done on the toilet, I started to stand up and lost my balance. I tried to reach for the door jam but missed and fell backwards onto the toilet and sat hard and hit my back very hard against the top of the toilet.  I helped back to bed by boyfriend but had to get up several more times that morning and had the same weakness in my legs and no control over my bladder. My boyfriend had to leave to go home, so I called my sister to come and stay with me in case I couldn't get up again. One she was here, I ate a small amount of roast chicken and slept most of the afternoon. I slept thru the night and felt stronger the next day. I felt very tired and sleepy for the next couple of days, but (3 days later) am now feeling and moving in a more normal manner.
This spontaneous report was received from a healthcare worker referring to a 5 month old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 29-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
"Ache" in left humerus. Left 4th ring finger numb and weak. Left arm numb and weak. It began about 2 weeks post shot. Shot given 11/12/2003.